Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2021-08 Issue:8 Volume:27 Page:660.e1-660.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Hotta Masaaki,Satake Atsushi,Yoshimura Hideaki,Fujita Shinya,Katayama Yuta,Ota Shuichi,Hanamoto Hitoshi,Oyake Tatsuo,Ito Shigeki,Okada Masaya,Nakanishi Takahisa,Ito Tomoki,Ishii Kazuyoshi,Nomura Shosaku

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference36 articles.

1. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation;Majhail;Biol Blood Marrow Transplant,2015

2. Graft-versus-host disease;Ferrara;Lancet,2009

3. Acute graft-versus-host disease - biologic process, prevention, and therapy;Zeiser;N Engl J Med,2017

4. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010

5. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis;Blood Advances;2024-04-23

2. Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology;Science Advances;2023-03-24

3. Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-02

4. Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation;Clinical and Applied Thrombosis/Hemostasis;2023-01

5. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease;Transplantation and Cellular Therapy;2022-10